Taken together, these data suggest an important cancer participation of an altered expression of miR-650 through 22q11.2 alterations by targeting different TSG, such as PER2 in leukemias and lymphomas, THBD in thyroid cancer, and both of them plus STAT5 in BRCA. This evidence concerns the gene STAT5A and thyroid cancer.